BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA)

biomedical-advanced-research-and-development-authority-barda-logo

The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.

#SimilarOrganizations #People #Financial #Website #More

BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA)

Social Links:

Industry:
Biotechnology Health Care

Founded:
2006-01-01

Address:
Washington, District Of Columbia, United States

Country:
United States

Website Url:
http://www.medicalcountermeasures.gov

Total Employee:
251+

Status:
Active

Contact:
202-260-1200

Email Addresses:
[email protected]

Technology used in webpage:
SPF


Similar Organizations

allegheny-health-network-logo

Allegheny Health Network

Allegheny Health Network is a healthcare facility specializing in primary care, neuroscience, and mental health services.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

nantworks-logo

NantWorks

NantWorks combines semiconductor technology, supercomputing and advanced networks to improve healthcare, commerce and digital entertainment.

Current Employees Featured

rick-bright_image

Rick Bright
Rick Bright Director @ Biomedical Advanced Research and Development Authority (BARDA)
Director

Investments List

Date Company Article Money raised
2022-08-31 Arcturus Therapeutics Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Arcturus Therapeutics 63.2 M USD
2022-08-30 Spectral MD Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Spectral MD 8.2 M USD
2022-08-24 Everglade Consulting Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Everglade Consulting 39 M USD
2022-07-12 SeLux Diagnostics Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - SeLux Diagnostics 8 M USD
2022-05-03 BugSeq Bioinformatics Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - BugSeq Bioinformatics N/A
2022-03-22 Visby Medical Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Visby Medical 25.5 M USD
2022-03-01 The Stevanato Group Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - The Stevanato Group 95 M USD
2022-01-25 Opiant Pharmaceuticals Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Opiant Pharmaceuticals 2 M USD
2022-01-19 Spero Therapeutics Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Spero Therapeutics 12.9 M USD
2022-01-06 Cue Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Cue N/A

Official Site Inspections

http://www.medicalcountermeasures.gov Semrush global rank: 3.33 M Semrush visits lastest month: 4.83 K

  • Host name: 130.213.136.244
  • IP address: 130.213.136.244
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Biomedical Advanced Research and Development Authority (BARDA)"

ABOUT BARDA - Medical Countermeasures

Linda C. Lambert, Ph.D. is the Principal Deputy Director and Director of Medical Countermeasures Program Support Services (MCPSS) for the Biomedical Advanced โ€ฆSee details»

Who We Are - Medical Countermeasures

A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS. A lock or https:// means youโ€™ve safely connected to the .gov website. ...See details»

Medical Countermeasures and Biodefense - ASPR

Learn about our strategic objectives, current preparedness activities, and future research priorities,See details»

Public Health Emergency Medical Countermeasures Enterprise

Public Health Emergency Medical Countermeasures Enterprise. The PHEMCE is an interagency partnership of federal medical countermeasure experts who collaborate across sectors to โ€ฆSee details»

What are Medical Countermeasures? | FDA

Oct 1, 2024 Medical countermeasures, or MCMs, are FDA-regulated products (biologics, drugs, devices) that may be used in the event of a potential public health emergencySee details»

Medical Countermeasure Resources - FDA

Oct 1, 2024 Information related to medical countermeasures and public health emergency preparedness from the FDA and government partners. ... (PRET) (World Health Organization) Ready.gov (learn to plan ahead ...See details»

Medical Countermeasures (MCMs) | FDA

Oct 1, 2024 The FDA coordinates medical countermeasure development, preparedness, and response. Learn more about how the FDA is protecting national health and security.See details»

Medical Countermeasures Coalition | Public Health Preparedness

Public-Private Partnerships: Our experts have served as leaders in both the public and private sector and convene key actors from industry, academia, and government. Global โ€ฆSee details»

Project NextGen: Next Generation Medical โ€ฆ

BARDA, in collaboration with the National Institute of Allergy and Infectious Diseases, is supporting the development of next generation medical countermeasures, including vaccines and therapeutics, to protect Americans โ€ฆSee details»

3.2 Medical Countermeasures - FEMA.gov

Jun 2, 2023 Once the cause of disease is known, MCMs that effectively treat or prevent the disease can be utilized, if available. Effective use of MCMs during a biological incident will not only help reduce the spread of disease but also โ€ฆSee details»

Medical Countermeasures (MCMs) - fda.report

Jun 1, 2020 Title: Medical Countermeasures (MCMs) Author: FDA Subject: medical countermeasures Keywords: MCMs, medical countermeasures, CBRN, FDA, EUA, โ€ฆSee details»

Vaccine and Other Medical Countermeasures | Pandemic Flu | CDC

Jun 10, 2024 Vaccine and Medical Countermeasures. Safe, effective, and readily available MCMs, including vaccines, antiviral drugs, therapeutics, diagnostics, ventilators, and โ€ฆSee details»

About MCMs | FDA - U.S. Food and Drug Administration

Oct 1, 2024 The FDA works with government agencies, non-government organizations, universities, and research centers to support public health preparedness and response efforts. โ€ฆSee details»

Medical Countermeasures: Mission, Method, and Management

A .gov website belongs to an official government organization in the United States . Secure .gov websites use HTTPS ... The Strategic National Stockpile is a cache of pharmaceuticals and โ€ฆSee details»

Monitoring and Assessment of Medical Countermeasures as Part โ€ฆ

For more than a decade, the US government has developed and refined the capabilities necessary to rapidly distribute, dispense, and administer MCMsโ€”what many traditionally call โ€ฆSee details»

Advancing development of medical countermeasures: โ€ฆ

Partnerships included BARDA support for clinical and non-clinical development, and manufacturing scale-up and validation, and both programs achieved EUA less than 12 months โ€ฆSee details»

Preparedness and Responseโ€”Global Regulatory Approvals for โ€ฆ

Jul 29, 2024 Figure: During outbreaks, medical countermeasures (MCMs) with data packages that can support approval by stringent regulatory authority (SRAs) can expedite local โ€ฆSee details»

HHS plans to shutter or downsize several health agencies ... - NBC โ€ฆ

4 days ago The Department of Health and Human Services said Thursday it plans to cut 10,000 full-time jobs across several agencies, as part of a broader effort by the Trump administration โ€ฆSee details»

COVID-19 Portfolio - Medical Countermeasures

BARDAโ€™s Broad Agency Announcement (BAA) sets forth the advanced research and development Areas of Interest (AOIs) and solicits proposals focusing on these areas in order โ€ฆSee details»

Full article: Overcoming barriers to medical countermeasures ...

Mar 25, 2025 Diagnostics. LMICs face barriers along the diagnostic value chain, which reduces their effectiveness and efficiency. Citation 32, Citation 33 The 2022 PATH report highlights โ€ฆSee details»

linkstock.net © 2022. All rights reserved